sickle cell trait screen test with reflex

Red blood cells (erythrocytes) are the oxygen-carrying cells in your blood. This automated test counts the number of red blood cells in synovial fluid (joint fluid), which is abnormal since red blood cells should not be present in joints. Elevated RBC counts in joint fluid may indicate joint injury, bleeding into the joint, or traumatic arthrocentesis (needle puncture during fluid collection). This result helps differentiate between inflammatory and non-inflammatory joint conditions.

This test involves newborn screening for hemoglobin disorders—genetic conditions affecting red blood cell function, such as sickle cell disease and thalassemia. Blood is collected from a newborn heel prick on a filter card. Early detection allows for immediate treatment and management, preventing serious complications like pain crises, organ damage, and death. Most U.S. states include hemoglobin screening in routine newborn panels. Results include interpretive comments guiding follow-up testing and pediatric care.

Hemoglobin E is an abnormal hemoglobin variant resulting from a genetic mutation in the beta-globin chain. This qualitative test detects the presence or absence of hemoglobin E through blood electrophoresis. Individuals with hemoglobin E trait carry one copy of the mutation and typically have mild or no symptoms. Those with hemoglobin E disease (two copies) may experience hemolytic anemia, fatigue, and jaundice. This test is important for genetic screening, particularly in populations where the mutation is more common.

Hemoglobin F (fetal hemoglobin) is normally present in high amounts before birth but decreases after birth as adult hemoglobin takes over. In adults, elevated hemoglobin F can indicate inherited blood disorders like sickle cell disease, thalassemia, or hereditary persistence of fetal hemoglobin. It can also be elevated in conditions causing bone marrow stress or hemolytic anemia. This qualitative test detects the presence of hemoglobin F and helps diagnose genetic blood disorders.

Hemoglobin C is an abnormal hemoglobin variant caused by a genetic mutation in the beta-globin chain. This qualitative test detects hemoglobin C through blood electrophoresis. Individuals with hemoglobin C trait carry one copy and usually have no symptoms. Those with hemoglobin C disease (two copies) may experience mild hemolytic anemia, jaundice, and spleen enlargement. This test is important for genetic screening and is most common in populations with African ancestry.

This newborn screening panel measures hemoglobin types and levels from a blood spot collected from heel pricks. It detects sickle cell disease, thalassemia, and other hemoglobinopathies that affect oxygen-carrying capacity. Early detection allows immediate treatment to prevent serious complications like pain crises, organ damage, and stroke. This screening is performed on all newborns in most countries and is critical for infant health outcomes.

Mean sphered cell volume measures the average size of red blood cells when treated under standardized laboratory conditions. This specialized test provides information about red blood cell shape and hydration status, helping diagnose hemolytic anemias and hereditary conditions affecting RBC structure like spherocytosis. Abnormal values suggest specific types of anemia or blood disorders requiring further investigation and targeted treatment.

Hemoglobin is the iron-containing protein in red blood cells that carries oxygen throughout your body. A hemoglobin test measures the total amount of hemoglobin in blood, revealing whether you have anemia (too little) or polycythemia (too much). Low hemoglobin causes fatigue, shortness of breath, and weakness, while high levels can increase clot risk. This is one of the most common tests in clinical medicine and a core part of the complete blood count.

The erythrocyte sedimentation rate (ESR) measures how quickly red blood cells settle in a test tube over one hour. This simple test reflects inflammation levels in your body. Elevated ESR can indicate infections, autoimmune diseases, inflammatory conditions, or certain cancers. Low ESR is less common but may occur with blood disorders. ESR is often used alongside other tests to diagnose or monitor chronic inflammatory conditions, though it's not specific to any single disease.

This test detects the presence of hemoglobin (blood) in stool samples, which may indicate bleeding in the lower gastrointestinal tract. Blood in stool can originate from the colon, rectum, or anus and may result from various conditions including hemorrhoids, polyps, inflammatory bowel disease, diverticulosis, or infections. Visible blood appears red or dark, while microscopic blood is only detectable by laboratory testing. This test helps identify gastrointestinal bleeding and guide further diagnostic evaluation if needed.

Hemoglobin S (HbS) is an abnormal form of hemoglobin associated with sickle cell disease. This test detects the presence of HbS using electrophoresis. Hemoglobin S polymerizes under low-oxygen conditions, causing red blood cells to assume a sickle shape, which damages blood vessels and organs. The test distinguishes between sickle cell disease (two HbS genes), sickle cell trait (one HbS gene), and normal hemoglobin. Sickle cell disease causes pain, organ damage, and shortened lifespan. Early detection enables disease monitoring and preventive treatments. Screening is especially important for people of African, Mediterranean, or Middle Eastern descent.

Hemoglobin A (HbA) is the normal predominant form of hemoglobin in adult red blood cells, making up about 95-98% of total hemoglobin. This test quantifies HbA percentage using electrophoresis. Hemoglobin electrophoresis separates different hemoglobin types to screen for disorders like sickle cell disease, thalassemia, and other hemoglobinopathies. Low HbA percentage indicates abnormal hemoglobin variants are present. This test is essential for diagnosing inherited blood disorders, especially in at-risk populations, and is often performed on newborns as part of screening programs.

CD19 is a marker found on B lymphocytes, white blood cells that produce antibodies and fight infections. A CD19 cell count measures the number of B cells in your blood or bone marrow. Abnormally low CD19 counts may indicate immunodeficiency, leukemia, or complications from certain medications or treatments. Elevated counts can suggest chronic lymphocytic leukemia or other lymphoproliferative disorders. This test is particularly useful in diagnosing blood cancers and immune disorders.

This newborn screening test detects hemoglobin disorders using a small blood sample from a heel prick on a dried blood spot card. It identifies conditions like sickle cell disease and thalassemia, which cause abnormal hemoglobin production. Early detection through newborn screening allows immediate treatment and monitoring to prevent serious complications, including pain crises, organ damage, and stroke.